honert
  • Practice Areas
    • Corporate / M&A
      • Overview
      • Mergers & Acquisitions
      • Corporate Law
      • Capital Market Law
      • Financing
    • Tax
      • Overview
      • Tax Advice and Tax Proceedings
      • Reorganization Tax
      • Transaction Tax
      • Asset Management and Succession Planning
      • International Tax
    • Litigation
      • Overview
      • Corporate / Commercial Litigation
      • Labor and Employment Law
      • Post-Acquisition Disputes
    • Employment
      • Overview
      • Restructuring
      • Employment Law
      • Labor
  • Professionals
    • Hamburg
      • show all
      • Julian Bahnsen
      • Dr. Malte Drews
      • Irina Eppenstein
      • Christina Frigger
      • Dr. Arne Hansen, LL.M.
      • Dr. Jan-Christian Heins
      • Florian Leßniak
      • Dr. Claudius Mann
      • Ferdinand Meyer-Miethke
      • Nick Miller
      • Sebastian Schleehauf
      • Timo Senger
      • Dr. Peter Slabschi, LL.M.
      • Dr. Franziska Strobel, LL.M.
      • Dr. Anja Wiedemann
      • Dr. Jörn-Ahrend Witt
    • Munich
      • show all
      • Dr. Simon Busch, LL.M.
      • Nicole Bühler
      • Dr. Thomas Grädler, LL.M.
      • Dr. Jürgen Honert
      • Bastian Hosp
      • Judith Kutter
      • Susanne Labus
      • Tobias Lämmle
      • Dr. Hanspeter Maute
      • Dr. Jochen Neumayer
      • Deniz Özkan
      • Stefan Rucker
      • Dr. Jörg Schwichtenberg
      • Patrick Spalek
      • Felix Strobel
      • Martin Walter-Schunke
      • Samuel Wimmer
      • Dr. Kai-Klemens Wehlage
      • Arik Widenhorn
  • Careers
  • News
  • Contact
  • English
    • Deutsch
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

News

Latest Topics

honert advises the founders of OmicEra Diagnostics GmbH on the sale to the stock exchange listed US-based company Exact Sciences Corporation

6. May 2022/in Deal Announcements/by Ester Hahn
Read more
https://honert.de/wp-content/uploads/honert_logo_270px.png 0 0 Ester Hahn https://honert.de/wp-content/uploads/honert_logo_270px.png Ester Hahn2022-05-06 10:54:542022-08-10 09:29:02honert advises the founders of OmicEra Diagnostics GmbH on the sale to the stock exchange listed US-based company Exact Sciences Corporation

honert advises SIVIS on the acquisition of the Danish Identity & Access Management (IAM) provider 2ndC

2. May 2022/in Deal Announcements/by Ester Hahn

honert has advised software specialist SIVIS, backed by Main Capital Partners (“Main”), on the acquisition of 2ndC, a leading provider of Identity & Access Management (IAM) solutions in the Danish market, as part of SIVIS’ buy-and-build strategy. The investment represents SIVIS’ first add-on acquisition and will enable the company to complement its product offering with […]

Read more
https://honert.de/wp-content/uploads/honert_logo_270px.png 0 0 Ester Hahn https://honert.de/wp-content/uploads/honert_logo_270px.png Ester Hahn2022-05-02 08:43:472022-08-10 09:32:05honert advises SIVIS on the acquisition of the Danish Identity & Access Management (IAM) provider 2ndC

honert advises Main Capital Partners on the acquisition of the recruitment specialist concludis

12. April 2022/in Deal Announcements/by Ester Hahn

honert advised the HR software provider Perbility, which is supported by Main Capital Partners („Main“), on the acquisition of concludis, a German market leader in recruitment software. The acquisition strengthens Perbility’s HR suite and enables concludis’ clients to benefit from Perbility’s extended product range.

Read more
https://honert.de/wp-content/uploads/honert_logo_270px.png 0 0 Ester Hahn https://honert.de/wp-content/uploads/honert_logo_270px.png Ester Hahn2022-04-12 08:57:572022-08-10 09:39:37honert advises Main Capital Partners on the acquisition of the recruitment specialist concludis

honert advises ATHOS on Strategic Partnership with Formycon in the Field of Biosimilar

11. April 2022/in Deal Announcements/by Ester Hahn
Read more
https://honert.de/wp-content/uploads/honert_logo_270px.png 0 0 Ester Hahn https://honert.de/wp-content/uploads/honert_logo_270px.png Ester Hahn2022-04-11 08:51:162022-04-11 08:51:17honert advises ATHOS on Strategic Partnership with Formycon in the Field of Biosimilar

honert advises Main Capital Partners on the acquisition of four companies in the DACH region for the enventa group

6. April 2022/in Deal Announcements/by Ester Hahn

honert has advised Main Capital Partners (“Main”) on the acquisition of a majority in the companies Nissen & Velten Software GmbH (ERP), texdata Software GmbH (ERP), aruba informatik GmbH (BI) and Litreca AG (financial solutions). Together, the four companies will form a new business software group to be called enventa.

Read more
https://honert.de/wp-content/uploads/honert_logo_270px.png 0 0 Ester Hahn https://honert.de/wp-content/uploads/honert_logo_270px.png Ester Hahn2022-04-06 16:05:172022-08-10 09:41:15honert advises Main Capital Partners on the acquisition of four companies in the DACH region for the enventa group

CORPORATE TRANSACTIONS AND THE GDPR: DATA PROTECTION OBSTACLES IN DUE DILIGENCE AND ASSET DEALS

4. April 2022/in 2022 Q1/by Ester Hahn

The GDPR is not only omnipresent on the Internet, where it says “We use cookies” e.g. on websites of bakeries, but it also has an impact on (almost) every area of law, including the transaction business. In order to illustrate this, two aspects will be examined in more detail below, firstly the data protection law factors in due diligence in the preliminary stages of a sale, and secondly the handling of personal data by the buyer after an asset deal. In both cases, a “standard market” approach has not yet developed.

Read more
https://honert.de/wp-content/uploads/honert_logo_270px.png 0 0 Ester Hahn https://honert.de/wp-content/uploads/honert_logo_270px.png Ester Hahn2022-04-04 12:14:262022-04-04 12:14:27CORPORATE TRANSACTIONS AND THE GDPR: DATA PROTECTION OBSTACLES IN DUE DILIGENCE AND ASSET DEALS
Page 25 of 55«‹2324252627›»

Newsletter issues

  • 2026 Q1
  • 2025 Q4
  • 2025 Q3
  • 2025 Q2
  • 2025 Q1
  • 2024 Q4
  • 2024 Q3
  • 2024 Q2
  • 2024 Q1
  • 2023 Q4
  • 2023 Q2
  • 2023 Q1
  • 2022 Q4
  • 2022 Q3
  • 2022 Q2
  • 2022 Q1
  • 2021 Q4
  • 2021 Q3
  • 2021 Q2
  • 2021 Q1
  • 2020 Q4
  • 2020 Q3
  • 2020 Q2
  • 2020 Q1
  • 2019 Q4
  • 2019 Q3
  • 2019 Q2
  • 2019 Q1
  • 2018 Q4
  • 2018 Q3
  • 2018 Q2
  • 2018 Q1
  • 2017 Q4
  • 2017 Q3
  • 2017 Q2
  • Deal Announcements
  • Uncategorized

Newsletter

Subscribe
Unsubscribe

© 2022 honert
  • Privacy Policy
  • Legal Notice
Scroll to top Scroll to top Scroll to top